{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-22-000069","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.222434+00:00","generated_at":"2026-06-22T15:47:36.234639+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Humana reports Q3 GAAP EPS $9.39, adjusted EPS $6.88; reaffirms FY2022 adjusted EPS ~$25.00","bullets":["Q3 revenue $22.8B vs $20.7B a year ago; benefits expense ratio improved to 85.6% from 87.1%.","Adjusted EPS $6.88 vs $4.83 in Q3 2021; YTD adjusted EPS $23.58 vs $19.40.","FY2022 adjusted EPS guidance affirmed at ~$25.00, representing 21% growth over FY2021.","96% of Medicare Advantage members in 4-star+ contracts; 66% in 4.5+ star; industry leader.","Anticipates 2023 individual MA membership growth of 325k-400k (7.1%-8.7% growth)."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-22-000069","json":"https://secwatch.observer/filing/0000049071-22-000069.json","markdown":"https://secwatch.observer/filing/0000049071-22-000069.md","text":"https://secwatch.observer/filing/0000049071-22-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907122000069/0000049071-22-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907122000069/hum-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T15:47:36.234639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0405aaa6ea640cd86c094f9a51f373a85bd729f9","claim":"HUMANA INC reported the quarter ended September 30, 2022 (3Q22) results: revenue $22,799, EPS $9.39. Guidance reaffirmed.","evidence_excerpt":"YTD 2022 to YTD 2021. 2 Humana Inc. Summary of Results (dollars in millions, except per share amounts) 3Q22 (a) 3Q21 (b) YTD 2022 (c) YTD 2021 (d) CONSOLIDATED Revenues - GAAP $22,799 $20,697 $70,431 $62,010 Revenues - Adjusted (non-GAAP) $22,748 $20,871 $70,550 $62,207 Pretax income - GAAP $1,297 $1,636 $3,639 $3,414 Pretax income - Adjusted (non-GAAP) $1,143","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907122000069/0000049071-22-000069-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022 (3Q22)"},{"label":"Revenue","value":"$22,799"},{"label":"EPS","value":"$9.39"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c096dd37e4c14bdbbe4e4e32407fc02abf19881c","claim":"HUMANA INC reported the nine months ended September 30, 2022 (YTD 2022) results: revenue $70,431, EPS $22.16. Guidance reaffirmed.","evidence_excerpt":"2021. 2 Humana Inc. Summary of Results (dollars in millions, except per share amounts) 3Q22 (a) 3Q21 (b) YTD 2022 (c) YTD 2021 (d) CONSOLIDATED Revenues - GAAP $22,799 $20,697 $70,431 $62,010 Revenues - Adjusted (non-GAAP) $22,748 $20,871 $70,550 $62,207 Pretax income - GAAP $1,297 $1,636 $3,639 $3,414 Pretax income - Adjusted (non-GAAP) $1,143 $802 $3,918","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907122000069/0000049071-22-000069-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine months ended September 30, 2022 (YTD 2022)"},{"label":"Revenue","value":"$70,431"},{"label":"EPS","value":"$22.16"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}